Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Extended lab space for product development, customer demos, and training
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Subscribe To Our Newsletter & Stay Updated
